Synaptogenix Inc (SNPX)

[Cyosol]

I don't think the employees are that unique and hard to replace (other than Dr. Alkon who's responsible for most patents). It's the patent portfolio and drug platform that would become the most valuable assets if results look good.

Any pharma company can find a way to manufacture and sell bryo now thanks to Dr. Wender. What they don't have is the IP rights to do so.

An acquisition would have to be approved by shareholders, while a partnership can be signed without that approval.

Either way it doesn't make much sense to speculate about something that depends on so many unknown factors.

I would say let's wait for the results first. Like you mentioned, it's only about 6 or so weeks left before they receive the data.